сhondroitin sulphate / М01А Х25 / Solution for injections in ampoules of 2 ml №10 (5х2) in a pack.
It inhibits the process of degeneration and stimulates the regeneration of cartilaginous tissue, has chondroprotective, anti-inflammatory, analgesic effect.
- Promotes the restoration of the articular bag and cartilage surfaces of the joints, prevents compression of the connective tissue, performs the role of lubrication of articular surfaces, normalizes the production of joint fluid, improves joint mobility, helps reduce pain intensity, improves quality of life.
- Slows the resorption of bone tissue and reduces calcium loss, accelerates the recovery of bone tissue.
Comb drug | M09AX | Capsules №60 (6х10) in blisters.
Combination drug to stimulate the restoration of cartilage tissue. Slows down the degeneration of cartilage tissue, reduces the activity of enzymes that destroy the articular cartilage. Helps reduce pain, improve joint function, reduces the need for nonsteroidal anti-inflammatory drugs in patients with osteoarthritis of the knee and hip joints.
- Used for the treatment of degenerative-dystrophic diseases of the joints and spinal column: primary and secondary osteoarthritis, shoulder-scapular periarthritis, spinal osteochondosis, fractures (to accelerate the formation of callus).
Chondroitin sulfate | М01А Х25 | Emulgel for external use 5% 40 g in a tube.
It inhibits the degeneration of cartilage tissue, has a chondroprotective effect, helps to restore the articular sac and cartilage surfaces of the joints, increases the production of intraarticular fluid, reduces pain in the affected joints and increases their mobility, and also slows the progression of osteoarthritis and osteochondrosis.
- Used to treat degenerative-dystrophic diseases of the joints and spine (mostly localized forms): osteoarthrosis and osteochondrosis.
Desloratadine | R06 AX27 | Film coated tablets 5 mg, number 10 (10×1), number 20 (10×2) in blisters.
Studies have shown that antiallergic, antihistamine effect and anti-inflammatory, antipruritic and antiexudative action.
For the treatment and elimination of related symptoms:
- Allergic rhinitis (sneezing, nasal discharge, itching, edema and nasal congestion and itching and redness of eyes, watery eyes, itching and coughing palatine zone);
- Urticaria (itching, rash).
Ammonia | R07 AB | The solution for external use 10% in 40 mL (or 100 mL or 200 mL) in vials (glass or plastic).
Studies have shown that analeptic, antiseptic, antimicrobial activity and irritating when applied to the skin.
- For the treatment of unconscious conditions used, to moderate of insect bites applied.
Aminocaproic acid | B02 AA01 | Tablets 500 mg number 20 (10×2) in blisters, number 20 in containers.
Studies have shown that the hemostatic effect at bleeding associated with increased fibrinolysis; showing immunosuppressive, anti-inflammatory and anti-allergic activity.
- For hemostatic at bleeding by high blood fibrinolytic activity, and states hypo- and afibrinogenemia used; surgery on organs rich in fibrinolysis activators (lungs, brain, uterus, prostate, pancreas, thyroid, adrenal glands) at burn disease, complications of abortion, uterine bleeding, with internal diseases accompanied by hemorrhagic syndrome, liver diseases, acute pancreatitis, cholecystopancreatitis, pernicious and hypoplastic anemia, leukemia, allergic diseases (allergic rhinitis, chronic tonsillitis, rhinopathy, skin vasculitis, asthma).
Amlodipine | C08 CA01 | Tablets 5 mg number 20 (10×2), number 30 (10×3) in blisters.
Antihypertensive, antianginal effects registered.
- For the treatment of hypertension, chronic stable angina, in angiospastic angina (Prinzmetal angina) used.